Evidence map›Paper›PMID 36598024›Full record

ArticlePathology international2023

Impact of the COVID-19 pandemic on pathological autopsy practices in Japan.

Yuichiro Hirata, Shun Iida, Takeshi Arashiro, Sayaka Nagasawa, Hisako Saitoh, Hiroyuki Abe, Masako Ikemura, Yohsuke Makino, Rintaro Sawa, Hirotaro Iwase and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Pathology international, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Yuichiro HirataDepartment of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
Shun IidaDepartment of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.ORCID http://orcid.org/0000-0003-2258-9031
Takeshi ArashiroDepartment of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
Sayaka NagasawaDepartment of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba City, Japan.
Hisako SaitohDepartment of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba City, Japan.
Hiroyuki AbeDepartment of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0003-4513-1007
Masako IkemuraDepartment of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Yohsuke MakinoDepartment of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba City, Japan.ORCID http://orcid.org/0000-0002-0025-5252
Rintaro SawaJapan Medical Association Research Institute, Tokyo, Japan.
Hirotaro IwaseDepartment of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba City, Japan.
Tetsuo UshikuDepartment of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Tadaki SuzukiDepartment of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.ORCID http://orcid.org/0000-0002-3820-9542
Shinji AkitomiDepartment of Forensic Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Chiba University · JPNational Institute of Infectious Diseases · JPThe University of Tokyo · JPJapan Medical Association · JP

Funding

Japan Agency for Medical Research and Development JP22fk0108637Ministry of Health, Labour and Welfare 20HA2008
6 · The paper itself

Abstract

During the coronavirus disease 2019 (COVID-19) pandemic, autopsies have provided valuable insights into the pathogenesis of COVID-19. The precise effect of this pandemic on autopsy procedures in Japan, especially in instances unrelated to COVID-19, has not yet been established. Therefore, we conducted a questionnaire survey from December 2020 to January 2021 regarding the status of pathological autopsy practices in Japan during the first year of the COVID-19 pandemic. The questionnaire was sent to 678 medical facilities with pathologists, of which 227 responded. In cases where a confirmed diagnosis of COVID-19 was not made at the time of autopsy, many facilities counted them as suspected COVID-19 cases if pneumonia was suspected clinically. At around half of the sites, autopsies were prohibited for suspected COVID-19 cases. In addition, the number of autopsies of non-COVID-19 cases during the pandemic period was also investigated, and a significant decrease was observed compared with the incidence in the pre-pandemic period. The COVID-19 pandemic has affected not only the autopsies of COVID-19 cases but also the entire practice of pathological autopsies. It is necessary to establish a system that supports the implementation of pathological autopsy practices during the pandemic of an emerging infectious disease.

Indexed as

COVID-19AutopsyHumansJapanPandemicsSARS-CoV-2autopsyCOVID-19infection protectionPPESARS-CoV-2

Identifiers

PMID36598024
PMCPMC11551807
OpenAlexW4313488300

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.